<DOC>
	<DOCNO>NCT01861860</DOCNO>
	<brief_summary>Rationale IVUS show efficient bare metal stent deployment , specifically study Drug Eluting Stents . The angiographically versus IVUS optimization ( AVIO ) study perform ( medical device 's type ) Promus stent , result promise , study design clinical endpoint . There consensus IVUS criterion stent deployment . The MUSIC criterion widely use early 2000 , limitation complex long lesion . The AVIO criterion recently propose complex lesion , criterion also issue complexity make routine use challenge . We perform pilot study long complex lesion analysis use IVUS , order define easy use criterion , applicable complex lesion drug elute stent ( DES ) era . The new criterion ( OPERA ) adaptation MUSIC criterion . OTELLO study ongoing trial sponsor Boston Scientific Inc , determine Major Adverse Cardiac Event new TAXUS Element stent . 500 patient enrol study . Main question Is IVUS use simplify new criterion beneficial long ( &gt; 28mm ) TAXUS element stent deployment ? Study design This study consist prospectively include consecutive patient &gt; 28mm taxus element stent use IVUS . OPERA Criteria stent deployment objective reach . OPERA adaptation MUSIC criterion long complex lesion . The patient OTELLO study , inclusion criterion , compose control group . Population match use propensity score . 20 30 French center involve OTELLO study contact participate OPERA . Hypothesis : Long lesion percutaneous coronary intervention ( PCI ) specific characteristic like Diffuse old atheroma Calcifications Discrepancies prox distal diameter Infiltration longer target lesion Bifurcations Inhomogeneous strength due balloon ( Laplace law ) Primary hypothesis Long Taxus element deploy use IVUS OPERA criterion well outcomes without IVUS Primary Objectives 38 % MACE ( SAT , target lesion revascularization ( TLR ) , myocardial infarction ( MI ) , Death ) reduction use IVUS OPERA criterion Taxus element ≥ 28 mm implantation Secondary endpoint 1 . MACE determination Taxus element ≥ 28 mm implantation IVUS OPERA criterion 2 . Safety : procedural Stroke , Urgent cardiac surgery , procedural MI 3 . Comparison IVUS criterion : OPERA , MUSIC , AVIO Secondary objective Safety OPERA criterion Feasibility use OPERA criterion non expert IVUS center MACE determination 4 % margin error Taxus element ≥ 28 mm implantation IVUS OPERA criterion Methods Inclusion consecutive patient use IVUS Taxus element ≥ 28 mm multicentric study propensity score match analysis match comparison OTELLO study . ( Same inclusion criterion OTELLO ) Statistical analysis Primary Endpoint : MACE expect OTELLO study=18 % MACE expect OPERA study=11 % Number patient OTELLO study=500 Alpha=0.05,1- Beta=0.73 Number patient analysable OPERA study need =250 patient i.e 300 pt inclusion . Secondary Endpoint 4 % margin error MACE 11 % need also 250 pt Type study Biomedical research French study Centralized IVUS analysis 1 , 6 12 month telephone contact Safety efficacy measure Efficacy : MACE ( Cardiac Death , target vessel revascularization ( TVR ) , Myocardial Infarction ) 12 month Safety : procedure related event : Urgent surgery , According Good Clinical Practices serious adverse event ( SAE ) declare within 24 Hours</brief_summary>
	<brief_title>OPtimized Stenting Using Intravascular Ultrasound ( IVUS ) Long lEsion : Rationale Simplified criteriA</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Age &gt; 18 year Patients coronary angioplasty implantation TAXUS™ Element™ stent 28 , 32 38 mm length 3 stent per patient case acute occlusive dissection deploy use IVUS Patients indication Taxus™ Element™ stent include List Reimbursable Products Supplies ( LPPR ) : diabetes , small vessel ( le 3 mm diameter ) , long lesion ( ) ( 15 mm long ) , chronic total occlusion &gt; 1 month , intrastent restenosis exclusion drug elute stent ( ) , restenosis people lesion accessible IVUS stenting people provide consent collection medical data trial . Those refuse consent collection and/or process data necessary complete trial and/or centralize followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stenting use IVUS long lEsion</keyword>
</DOC>